Stock listing

NANO Stock Price, News, Filings & Events — Nanobiotix Sa

Selected listing: NANO · EURONEXT · EUR · FR

This page tracks Nanobiotix Sa's NANO:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NANO:EURONEXT. NANO:EURONEXT is the stock-level entry point for investors researching Nanobiotix Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nanobiotix Sa, traded under the ticker NANO, is a public company based in France with a market capitalization of approximately €1.99 billion. The company focuses on innovative cancer treatments using nanotechnology. Their approach aims to enhance the effectiveness of radiotherapy and improve patient outcomes.

NANO:EURONEXTEURFRUpdated August 28, 2026
Nanobiotix Sa logo
Ticker
NANO:EURONEXT
Asset type
Stock
Market cap
$2.28B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR

Nanobiotix Sa NANO:EURONEXT stock context

This page tracks Nanobiotix Sa's NANO:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NANO:EURONEXT. NANO:EURONEXT is the stock-level entry point for investors researching Nanobiotix Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nanobiotix Sa, traded under the ticker NANO, is a public company based in France with a market capitalization of approximately €1.99 billion. The company focuses on innovative cancer treatments using nanotechnology. Their approach aims to enhance the effectiveness of radiotherapy and improve patient outcomes.

Latest news from Nanobiotix Sa

All Nanobiotix Sa news →

Nanobiotix Sa earnings calls

Research Nanobiotix Sa

Alternate listings